The benefit of biventricular pacing in appropriate patients with congestive heart failure (CHF) now has been established in terms of both morbidity and mortality. [1,2,3,4,5] Current criteria for ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...
Conduction system pacing was found to be inferior to biventricular pacing for key outcomes in HFrEF with left bundle-branch ...
The BLOCK HF trial demonstrated that, during continual cardiac pacing, adverse left ventricular remodelling and deterioration of systolic function occurred more frequently with right ventricular than ...
Patients with indications for cardiac resynchronization therapy (CRT) have better clinical outcomes when they undergo left bundle branch area pacing (LBBAP) rather than conventional biventricular ...
Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Aug. 25, 2004--St. Jude Medical, Inc. (NYSE:STJ) announced today U.S. Food and Drug Administration (FDA) approval and first implants of the Frontier(TM) II ...
To the Editor: Yu et al. (Nov. 26 issue) 1 found that among patients with bradycardia, the left ventricular ejection fraction at 12 months was 7 percentage points lower in the patients who were ...
The global biventricular pacemakers market is on a sustained growth trajectory, with 2024 revenues estimated at $2.27 billion, building on the $2.1 billion recorded in 2023. Analysts forecast the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results